Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06206174
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-01-04
Brief Title:
TGRX-814 Chinese Phase III in Patients With Hematological Malignancies
Sponsor:
Organization:
Shenzhen TargetRx Inc